Neurologic Outcomes in HIV-Exposed/Uninfected Infants Exposed to Antiretroviral Drugs During Pregnancy in Latin America and the Caribbean.

@article{Spaulding2016NeurologicOI,
  title={Neurologic Outcomes in HIV-Exposed/Uninfected Infants Exposed to Antiretroviral Drugs During Pregnancy in Latin America and the Caribbean.},
  author={Alicen B Spaulding and Qilu Yu and Lucy Civitello and Marisa M{\'a}rcia Mussi-Pinhata and Jorge Andrade Pinto and Ivete Martins Gomes and Jorge O V Alarc{\'o}n and George K. Siberry and Donald Robert Harris and Rohan Hazra},
  journal={AIDS research and human retroviruses},
  year={2016},
  volume={32 4},
  pages={349-56}
}
To evaluate antiretroviral (ARV) drug exposure and other factors during pregnancy that may increase the risk of neurologic conditions (NCs) in HIV-exposed/uninfected (HEU) infants. A prospective cohort study was conducted at 24 clinical sites in Latin America and the Caribbean. Data on maternal demographics, health, HIV disease status, and ARV use during pregnancy were collected. Infant data included measurement of head circumference after birth and reported medical diagnoses at birth, 6-12… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS